AREV Life Sciences issues retention warrants
AREV Life Sciences issues retention warrants
Arev生命科学公司发布保留证
VANCOUVER, BC / TheNewswire / May 27, 2022 / AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREV) (OTC:AREVF) ("AREV" or the "Company") is pleased to announce the issuance of the retention warrant offering as announced April 8, 2022.
卑诗省温哥华/The Newswire/2022年5月27日/Arev生命科学全球公司。中国证券交易所股票代码：AREV)(场外交易代码：AREVF)(以下简称“AREV”或“公司”)欣然宣布于2022年4月8日发行保留权证。
AREV is pleased to announce a retention warrant offering to its senior management of Mike Withrow, CEO, and Kevin Phelps, COO. Each of the retention warrants are being sold to the purchase price of $0.05 per retention share purchase warrant and exercisable at $0.23 per common share during a term of 4 years from the date of closing of the retention warrant offering. The exercise of such warrant shall be subject to...
Arev很高兴地宣布向其高级管理层提供首席执行官迈克·威斯罗和首席运营官凯文·菲尔普斯的留任令。每份保留认股权证将以每股保留股份认购权证0...
登录免费看全文
登录/注册